Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report”

New Pharmaceuticals research report from MarketLine is now available from Fast Market Research

Boston, MA — (SBWIRE) — 01/23/2014 — Project Synopsis:

MarketLine’s Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Project Description:

MarketLines’ WuXi PharmaTech (Cayman), Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by WuXi PharmaTech (Cayman), Inc. since January 2007.

Scope:

– Provides intelligence on WuXi PharmaTech (Cayman), Inc.’s M&A, strategic partnerships and alliances, capital raising and private equity transactions.

– Detailed reports of various financial transactions undertaken by WuXi PharmaTech (Cayman), Inc. and its subsidiaries since 2007.

– Information about key financial and legal advisors for WuXi PharmaTech (Cayman), Inc.’s financial deals transactions.

– Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

View Full Report Details and Table of Contents at: http://www.fastmr.com/prod/765328_wuxi_pharmatech_cayman_inc_mergers_acquisitions.aspx

Highlights:

This report includes WuXi PharmaTech (Cayman), Inc.’s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by WuXi PharmaTech (Cayman), Inc.. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Reasons to Purchase:

– Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.

– Form an independent opinion about WuXi PharmaTech (Cayman), Inc.’s growth strategies through the organic and inorganic activities undertaken since 2007.

– Track your competitors’ business structure and growth strategies.

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. Representing the world’s top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff will help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.